Your browser doesn't support javascript.
loading
High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern.
Sabouni, F; Movahedi, Z; Mahmoudi, S; Pourakbari, B; Keshavarz Valian, S; Mamishi, S.
Afiliação
  • Sabouni F; Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Movahedi Z; Department of Pediatric Infectious Diseases, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
  • Mahmoudi S; Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Pourakbari B; Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Keshavarz Valian S; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mamishi S; Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran;; Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
J Prev Med Hyg ; 57(4): E201-E204, 2016 12.
Article em En | MEDLINE | ID: mdl-28167857
ABSTRACT

INTRODUCTION:

Enterococcus spp. is considered as important etiological agents of nosocomial infections. However, a little is known about the epidemiology of vancomycin resistant Enterococcus faecalis (VREF). The aim of this study was to investigate the frequency of VREF and detecting of two prevalent resistance genes (vanA, vanB) at Children Medical Center Hospital, an Iranian referral pediatric Hospital. MATERIALS AND

METHODS:

During January 2013 to December 2013, 180 E. faecalis were isolated from clinical samples of hospitalized children. Antimicrobial testing was performed by Kirby-Bauer disk diffusion to gentamicin, amikacin, ceftriaxone, cefotaxime, ceftazidim, cefixime, piperacillin/tazobactam, cefepime, trimethoprim/sulfamethoxazole, erythromycin, clindamycin, linezolide and E-test method vancomycin and teicoplanin according to Clinical Laboratories Standards Institute (CLSI). Two prevalent resistance genes (vanA, vanB) were investigated in VREF isolates.

RESULTS:

Seventy-five (42%) of patients were male and 105 (58%) were female. Mean age of patients was 34.74 months. Cephalosporin resistance was found in majority of E. faecalis isolates (98.7 to ceftazidim, 95% to cefixime, 93.3% to ceftriaxone, and 89.4% to cefotaxime). Most of the isolated were susceptible to cefepime (91.7%). In addition, high level of erythromycin and clindamycin resistance was reported (93.4% and 91.2%). There were no linezolid-resistant E. faecalis among all isolates. Teicoplanin resistance was observed in 13.8% of E. faecalis (n = 25). Minimum Inhibitory concentration (MIC) ≥ 32 µg/ml for vancomycin was found in 29 isolates (16%) and vanA gene was detected in 21 (72%) VREF strains, while vanB gene was not detected in any of these isolates. The mortality rate of all cases was 3.4%.

CONCLUSIONS:

This study revealed high rate of vancomycin resistance in E. faecalis strains. Therefore, periodic surveillance of antibacterial susceptibilities is highly recommended to detect emerging resistance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Positivas / Enterococcus faecalis / Resistência a Vancomicina Tipo de estudo: Guideline Limite: Child, preschool / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Positivas / Enterococcus faecalis / Resistência a Vancomicina Tipo de estudo: Guideline Limite: Child, preschool / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2016 Tipo de documento: Article